Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
58.36
+1.45 (2.55%)
At close: Mar 27, 2026
SHE:300049 Market Cap
SHE:300049 has a market cap or net worth of 15.46 billion as of March 27, 2026. Its market cap has increased by 72.07% in one year.
Market Cap
15.46B
Enterprise Value
15.40B
Revenue
1.60B
Ranking
n/a
PE Ratio
100.62
Stock Price
58.36
Market Cap Chart
Since January 20, 2010, SHE:300049's market cap has increased from 2.54B to 15.46B, an increase of 509.43%. That is a compound annual growth rate of 11.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 15.46B | -17.11% |
| Dec 31, 2025 | 18.66B | 122.08% |
| Dec 31, 2024 | 8.40B | -26.74% |
| Dec 29, 2023 | 11.47B | 78.43% |
| Dec 30, 2022 | 6.43B | 70.55% |
| Dec 31, 2021 | 3.77B | 80.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 18.46B |
| Anhui Anke Biotechnology (Group) | 15.42B |
| Jinyu Bio-technology | 14.93B |
| Vcanbio Cell & Gene Engineering Corp., | 14.53B |
| Mabwell (Shanghai) Bioscience | 14.51B |
| Tibet Cheezheng Tibetan Medicine | 13.02B |
| Chengzhi | 12.65B |
| Pacific Shuanglin Bio-pharmacy | 12.47B |